The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Quest Diagnostics

  • DGX
  • NYSE
  • Other Services
  • Latest 58.40
  • Currency US$
  • Change -0.90
  • Percent Change -1.518 %
  • Volume 2,401,816
  • Tue Apr 22, 2014 04:03 PM EDT NYSE data delayed 15 minutes.
  • Open 59.50
  • Previous Close 59.30
  • High 59.87
  • Low 58.37
  • Bidx4 49.88
  • Askx0 62.00
  • 52-week High11/11 64.10
  • 52-week Low02/07 50.46
  • Beta 0.535
  • Market Cap 8,493.11M
  • EPS 4.00
  • P/E 14.60
  • Forward P/E 13.52
  • PEG 1.37
  • Annual Dividend 1.32
  • Yield 2.26

News

Financials & Calendars

Income Statement

  • Sales $7,145,400,000
  • Earnings $849,400,000
  • Return on Equity 21.66%

Cash Flow

  • Cash Flow --
  • Cash $187,000,000
  • Current Ratio 1.22

12 months ended Dec 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $8,948,000,000
  • Liabilities $4,975,000,000
  • Liabilities-to-Equity Ratio 1.25

Price Ratios

  • Price to Sales 1.19
  • Price to Book 2.14
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Jan 30 $0.94 Apr 24 $0.89
Surprises Jan 30 9.57% n/a n/a
Dividends Apr 4 $0.33 n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 23, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.

Related Securities
Symbol Type Latest % Chg

Officers

  • Daniel C. Stanzione Chairman of the Board
  • Stephen H. Rusckowski President and Chief Executive
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

3 GIRALDA FARMS
MADISON, NJ
07940

Phone: (973)-520-2700
Fax: (201)-4624169

investor@questdiagnostics.com
www.questdiagnostics.com

Ideas & Discussion

Live Discussion of DGX on StockTwits